Literature DB >> 17641666

B-cell anergy: from transgenic models to naturally occurring anergic B cells?

John C Cambier1, Stephen B Gauld, Kevin T Merrell, Barbara J Vilen.   

Abstract

Anergy, a condition in which cells persist in the periphery but are unresponsive to antigen, is responsible for silencing many self-reactive B cells. Loss of anergy is known to contribute to the development of autoimmune diseases, including systemic lupus erythematosus and type 1 diabetes. Multiple transgenic mouse models have enabled the dissection of mechanisms that underlie anergy, and recently, anergic B cells have been identified in the periphery of wild-type mice. Heterogeneity of mechanistic concepts developed using model systems has complicated our understanding of anergy and its biological features. In this Review, we compare and contrast the salient features of anergic B cells with a view to developing unifying mechanistic hypotheses that explain their lifestyles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641666      PMCID: PMC3714009          DOI: 10.1038/nri2133

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  83 in total

Review 1.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

2.  Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling.

Authors:  Stephen B Gauld; Robert J Benschop; Kevin T Merrell; John C Cambier
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

3.  Low-affinity, Smith antigen-specific B cells are tolerized by dendritic cells and macrophages.

Authors:  Michelle A Kilmon; Jennifer A Rutan; Stephen H Clarke; Barbara J Vilen
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

4.  VH and VL gene usage by murine IgG antibodies that bind autologous insulin.

Authors:  U K Ewulonu; L J Nell; J W Thomas
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

5.  Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes.

Authors:  D A Nemazee; K Bürki
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

Review 6.  Clonal silencing of self-reactive B lymphocytes in a transgenic mouse model.

Authors:  C C Goodnow; J Crosbie; S Adelstein; T B Lavoie; S J Smith-Gill; D Y Mason; H Jorgensen; R A Brink; H Pritchard-Briscoe; M Loughnan
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

7.  Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice.

Authors:  C C Goodnow; J Crosbie; S Adelstein; T B Lavoie; S J Smith-Gill; R A Brink; H Pritchard-Briscoe; J S Wotherspoon; R H Loblay; K Raphael
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

8.  Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity.

Authors:  F K Stevenson; G J Smith; J North; T J Hamblin; M J Glennie
Journal:  Br J Haematol       Date:  1989-05       Impact factor: 6.998

9.  Induction of self-tolerance in mature peripheral B lymphocytes.

Authors:  C C Goodnow; J Crosbie; H Jorgensen; R A Brink; A Basten
Journal:  Nature       Date:  1989-11-23       Impact factor: 49.962

10.  Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice.

Authors:  J Erikson; M Z Radic; S A Camper; R R Hardy; C Carmack; M Weigert
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

View more
  159 in total

1.  Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy.

Authors:  Shannon K O'Neill; Andrew Getahun; Stephen B Gauld; Kevin T Merrell; Idan Tamir; Mia J Smith; Joseph M Dal Porto; Quan-Zhen Li; John C Cambier
Journal:  Immunity       Date:  2011-11-09       Impact factor: 31.745

Review 2.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

Review 3.  B Cells, Antibodies, and More.

Authors:  William Hoffman; Fadi G Lakkis; Geetha Chalasani
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

4.  Nur77 Links Chronic Antigen Stimulation to B Cell Tolerance by Restricting the Survival of Self-Reactive B Cells in the Periphery.

Authors:  Corey Tan; James L Mueller; Mark Noviski; John Huizar; Denise Lau; Alexandra Dubinin; Ari Molofsky; Patrick C Wilson; Julie Zikherman
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

Review 5.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Authors:  Karsten Sauer; Michael P Cooke
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

Review 6.  BAFF and selection of autoreactive B cells.

Authors:  Zheng Liu; Anne Davidson
Journal:  Trends Immunol       Date:  2011-07-13       Impact factor: 16.687

Review 7.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

8.  Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation.

Authors:  Anita N Kremer; Judith C van der Griendt; Edith D van der Meijden; M Willy Honders; Burcu Ayoglu; Jochen M Schwenk; Peter Nilsson; J H Frederik Falkenburg; Marieke Griffioen
Journal:  Haematologica       Date:  2013-10-04       Impact factor: 9.941

Review 9.  B cells and immunological tolerance.

Authors:  Nataly Manjarrez-Orduño; Tâm D Quách; Iñaki Sanz
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

10.  Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies.

Authors:  Jinsong Zhang; S Munir Alam; Hilary Bouton-Verville; Yao Chen; Amanda Newman; Shelley Stewart; Frederick H Jaeger; David C Montefiori; S Moses Dennison; Barton F Haynes; Laurent Verkoczy
Journal:  J Immunol       Date:  2014-01-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.